Tanaka Masako 田中昌子

… Alternative Names

橘昌子

橘昌子タチバナマサコ

田中昌子

田中昌子(橘昌子) タナカマサコ

Less

Researcher Number	00733651
Other IDs	https://orcid.org/0000-0002-4484-1712
Affiliation (based on the past Project Information) *help	2022: 関西学院大学, 生命環境学部, 講師 2018 – 2021: 早稲田大学, 高等研究所, 講師(任期付) 2017: 早稲田大学, 理工学術院, 助教 2015: 大阪市立大学, 大学院医学研究科, 助教 2015: 大阪市立大学, 大学院医学研究科, 特任助教 2014: 大阪市立大学, 医学(系)研究科(研究院), 助教
Review Section/Research Field	Principal Investigator Basic Section 48030:Pharmacology-related / Applied pharmacology / Tumor therapeutics
Keywords	Principal Investigator 胃がん / 抗がん剤耐性 / インタラクトーム / プロテオスタシス / 分子シャペロン / 多剤耐性 / ストレス応答 / 小胞体ストレス応答 / 胃がん細胞株 / カルシウム恒常性 … More / オキサリプラチン / 膵癌 / 熱ショックタンパク質 / 薬剤耐性 Less

Identification of multidrug resistance factors by analysis of Hsp70-interacting proteinsPrincipal Investigator
- Principal Investigator
  
  Tanaka Masako
- Project Period (FY)
  2019 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 48030:Pharmacology-related
- Research Institution
  Kwansei Gakuin University
  Waseda University
SDF-2 is involved in oxaliplatin resistance by maintaining ER homeostasisPrincipal Investigator
- Principal Investigator
  
  Tanaka Masako
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Applied pharmacology
- Research Institution
  Waseda University
HSP72 interactome identifies key molecules for intrinsic resitance to gemcitabine in pancreatic cancerPrincipal Investigator
- Principal Investigator
  
  Tanaka Masako
- Project Period (FY)
  2014 – 2015
- Research Category
  
  Grant-in-Aid for Research Activity Start-up
- Research Field
  
  Tumor therapeutics
- Research Institution
  Osaka City University

All 2020 2019 2018 2017 2016 2015 2014 Other

All Journal Article Presentation

[Journal Article] Generation of Rat Monoclonal Antibodies Specific for Human Stromal Cell-Derived Factor-22020
- Author(s)
  Tanaka Masako、Shiota Masayuki、Koyama Masaru、Nakayama Jun、Yashiro Masakazu、Semba Kentaro、Goda Nobuhito
- Journal Title
  
  Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
  
  Volume: 39 Issue: 1 Pages: 23-26
- DOI
  10.1089/mab.2019.0043
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K16506, KAKENHI-PROJECT-17K15757
[Journal Article] A dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, attenuates cardiac dysfunction after myocardial infarction independently of DPP-42019
- Author(s)
  Yamaguchi Takehiro、Watanabe Ayano、Tanaka Masako、Shiota Masayuki、Osada-Oka Mayuko、Sano Soichi、Yoshiyama Minoru、Miura Katsuyuki、Kitajima Shojiro、Matsunaga Shinji、Tomita Shuhei、Iwao Hiroshi、Izumi Yasukatsu
- Journal Title
  
  Journal of Pharmacological Sciences
  
  Volume: 139 Issue: 2 Pages: 112-119
- DOI
  10.1016/j.jphs.2018.12.004
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K08602, KAKENHI-PROJECT-17K08958, KAKENHI-PROJECT-17K15757, KAKENHI-PROJECT-15K08649
[Journal Article] HIF-1-dependent lipin1 induction prevents excessive lipid accumulation in choline-deficient diet-induced fatty liver2018
- Author(s)
  Arai Takatomo、Tanaka Masako、Goda Nobuhito
- Journal Title
  
  Scientific Reports
  
  Volume: 8 Issue: 1 Pages: 14230-14230
- DOI
  10.1038/s41598-018-32586-w
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K15757, KAKENHI-PLANNED-26111003
[Journal Article] Role of hypoxia-inducible factor-1 in the development of renal fibrosis in mouse obstructed kidney: Special references to HIF-1 dependent gene expression of profibrogenic molecules2018
- Author(s)
  Kabei Kazuya、Tateishi Yu、Nozaki Masakazu、Tanaka Masako、Shiota Masayuki、Osada-Oka Mayuko、Nishide Shunji、Uchida Junji、Nakatani Tatsuya、Tomita Shuhei、Miura Katsuyuki
- Journal Title
  
  Journal of Pharmacological Sciences
  
  Volume: 136 Issue: 1 Pages: 31-38
- DOI
  10.1016/j.jphs.2017.12.004
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K08602, KAKENHI-PROJECT-17K08958, KAKENHI-PROJECT-17K15757
[Journal Article] Heat shock protein 70 inhibitors suppress androgen receptor expression in LNCaP95 prostate cancer cells2017
- Author(s)
  Kita Kazuaki、Shiota Masayuki、Tanaka Masako、Otsuka Asuka、Matsumoto Masaki、Kato Minoru、Tamada Satoshi、Iwao Hiroshi、Miura Katsuyuki、Nakatani Tatsuya、Tomita Shuhei
- Journal Title
  
  Cancer Sci
  
  Volume: 108 Issue: 9 Pages: 1820-1827
- DOI
  10.1111/cas.13318
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K08602, KAKENHI-PROJECT-17K15757
[Journal Article] A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Guéren.2015
- Author(s)
  2)Ozeki Y, Igarashi M, Doe M, Tamaru A, Kinoshita N, Ogura Y, Iwamoto T, Sawa R, Umekita M, Enany S, Nishiuchi Y, Osada-Oka M, Hayashi T, Niki M, Tateishi Y, Hatano M, Matsumoto S.
- Journal Title
  
  PLoS One
  
  Volume: 10 Pages: 214-221
- DOI
  10.1016/j.jprot.2016.01.008
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15K15132, KAKENHI-PUBLICLY-15H01407, KAKENHI-PLANNED-25116010, KAKENHI-PROJECT-25290078, KAKENHI-PROJECT-26290064, KAKENHI-PUBLICLY-26116721, KAKENHI-PROJECT-26890021, KAKENHI-PROJECT-26460344
[Journal Article] Establishment of neutralizing rat monoclonal antibodies for fibroblast growth factor-22014
- Author(s)
  Tanaka M, Yamaguchi M, Shiota M, Kawamoto Y, Takahashi K, Inagaki A, Osada-Oka M, Harada A, Wanibuchi H, Izumi Y, Miura K, Iwao H, Ohkawa Y.
- Journal Title
  
  Monoclon Antib Immunodiagn Immunother
  
  Volume: 33 Issue: 4 Pages: 261-269
- DOI
  10.1089/mab.2013.0085
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-13J04024, KAKENHI-PROJECT-24390064, KAKENHI-PROJECT-26340042, KAKENHI-PROJECT-26890021, KAKENHI-PROJECT-221S0001
[Journal Article] Hsc70 contributes to cancer cell survival by preventing Rab1A degradation under stress conditions.2014
- Author(s)
  Tanaka M, Mun S, Harada A, Ohkawa Y, Inagaki A, Sano S, Takahashi K, Izumi Y, Osada-Oka M, Wanibuchi H, Yamagata M, Yukimura T, Miura K, Shiota M, Iwao H.
- Journal Title
  
  PLoS One
  
  Volume: 9 Issue: 5 Pages: e96785-e96785
- DOI
  10.1371/journal.pone.0096785
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-13J04024, KAKENHI-PROJECT-24390064, KAKENHI-PROJECT-24501015, KAKENHI-PROJECT-26340042, KAKENHI-PROJECT-26890021, KAKENHI-PROJECT-221S0001
[Presentation] Hsp72によるがん細胞遊走制御2019
- Author(s)
  塩田正之、田中昌子、鰐渕英機、徳永文稔
- Organizer
  第14回日本臨床ストレス応答学会大会
- Data Source
  KAKENHI-PROJECT-17K15757
[Presentation] Hsp72によるがん細胞遊走制御2019
- Author(s)
  塩田正之、田中昌子、鰐渕英機、徳永文稔
- Organizer
  第14回日本臨床ストレス応答学会大会
- Data Source
  KAKENHI-PROJECT-19K16506
[Presentation] アンドロゲン受容体の発現抑制を介したHsp70阻害剤の去勢抵抗性前立腺がんLNCaP95に対する抗がん作用2018
- Author(s)
  田中　昌子、塩田　正之
- Organizer
  第13回臨床ストレス応答学会大会
- Data Source
  KAKENHI-PROJECT-17K15757
[Presentation] Stabilization of SDF-2 by Hsp72 contributes to oxaliplatin resistance in human gastric cancer cells2018
- Author(s)
  Masako Tanaka, Katsuyuki Takahashi, Katsuyuki Miura, Shuhei Tomita, Nobuhito Goda, Masayuki Shiota
- Organizer
  18th World Congress of Basic and Clinical Pharmacology
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K15757
[Presentation] 去勢抵抗性前立腺癌においHsp70阻害剤はアンドロゲン受容体の発現を抑制する2018
- Author(s)
  田中　昌子、塩田　正之
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17K15757
[Presentation] 胃がん細胞株における新規オキサリプラチン耐性因子SDF-2の同定2018
- Author(s)
  田中　昌子、八代　正和
- Organizer
  第22回日本がん分子標的治療学会学術集会
- Data Source
  KAKENHI-PROJECT-17K15757
[Presentation] Hsp72によるSDF-2の分解抑制はオキサリプラチン耐性の一因である2017
- Author(s)
  塩田正之、髙橋克之、八代正和、田中昌子
- Organizer
  第76回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17K15757
[Presentation] 膵がん細胞の低酸素および低血清耐性株はゲムシタビン耐性を示す2017
- Author(s)
  田中昌子、塩田正之、髙橋克之、合田亘人
- Organizer
  第1回がんと代謝研究会・若手の会
- Data Source
  KAKENHI-PROJECT-17K15757
[Presentation] Hsp72によるSDF-2の安定化はオキサリプラチン耐性の維持に重要である2017
- Author(s)
  田中昌子、髙橋克之、八代正和、合田亘人、塩田正之
- Organizer
  第12回臨床ストレス応答学会大会
- Data Source
  KAKENHI-PROJECT-17K15757
[Presentation] SDF-2はオキサリプラチン耐性に関与する2016
- Author(s)
  大塚明日香、髙橋克之、田中昌子、泉康雄、岩尾洋、塩田正之、三浦克之
- Organizer
  第89回日本薬理学会年会
- Place of Presentation
  パシフィコ横浜（神奈川県横浜市）
- Year and Date
  2016-03-09
- Data Source
  KAKENHI-PROJECT-26890021
[Presentation] ゲムシタビン耐性膵癌におけるHSP72結合タンパク質の同定2016
- Author(s)
  田中昌子、大塚明日香、髙橋克之、泉康雄、塩田正之、三浦克之
- Organizer
  第89回日本薬理学会年会
- Place of Presentation
  パシフィコ横浜（神奈川県横浜市）
- Year and Date
  2016-03-09
- Data Source
  KAKENHI-PROJECT-26890021
[Presentation] Stromal cell-derived factor 2はoxaliplatin耐性に寄与する2015
- Author(s)
  髙橋克之、田中昌子、塩田正之
- Organizer
  第74回日本癌学会学術総会
- Place of Presentation
  名古屋国際会議場（愛知県名古屋市）
- Year and Date
  2015-10-08
- Data Source
  KAKENHI-PROJECT-26890021
[Presentation] ゲムシタビン耐性ヒト膵癌細胞株における生存因子の同定2015
- Author(s)
  田中昌子、髙橋克之、泉康雄、塩田正之、三浦克之
- Organizer
  第127回日本薬理学会近畿部会
- Place of Presentation
  長良川国際会議場（岐阜県岐阜市）
- Year and Date
  2015-06-26
- Data Source
  KAKENHI-PROJECT-26890021
[Presentation] 膵癌細胞における低血清・低酸素耐性株の樹立とGemcitabine感受性の評価2014
- Author(s)
  市坪大将、田中昌子、髙橋克之、泉康雄、塩田正之、岩尾洋、三浦克之
- Organizer
  第126回日本薬理学会近畿部会
- Place of Presentation
  和歌山県JAビル（和歌山県和歌山市）
- Year and Date
  2014-10-24
- Data Source
  KAKENHI-PROJECT-26890021
[Presentation] Hsp72-TGFBI複合体はエンドリソソーム系によって分泌される
- Author(s)
  田中昌子、髙橋克之、市坪大将、鰐渕英機、塩田正之
- Organizer
  第73回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜（神奈川県横浜市）
- Year and Date
  2014-09-25 – 2014-09-27
- Data Source
  KAKENHI-PROJECT-26890021
[Presentation] 低血清・低酸素耐性膵癌細胞におけるゲムシタビン感受性の評価
- Author(s)
  市坪大将、田中昌子、髙橋克之、泉康雄、塩田正之、岩尾洋、三浦克之
- Organizer
  第88回日本薬理学会年会
- Place of Presentation
  名古屋国際会議場（愛知県名古屋市）
- Year and Date
  2015-03-18 – 2015-03-20
- Data Source
  KAKENHI-PROJECT-26890021
[Presentation] 膵癌細胞株PANC-1の環境ストレス耐性株樹立とゲムシタビン感受性への評価
- Author(s)
  市坪大将、田中昌子、髙橋克之、鰐渕英機、塩田正之
- Organizer
  第73回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜（神奈川県横浜市）
- Year and Date
  2014-09-25 – 2014-09-27
- Data Source
  KAKENHI-PROJECT-26890021
[Presentation] Stromal cell-drived factor 2はoxaliplatin耐性に寄与する
- Author(s)
  髙橋克之、田中昌子、塩田正之、泉康雄、三浦克之、岩尾洋
- Organizer
  第88回日本薬理学会年会
- Place of Presentation
  名古屋国際会議場（愛知県名古屋市）
- Year and Date
  2015-03-18 – 2015-03-20
- Data Source
  KAKENHI-PROJECT-26890021

1. 松永慎司

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
2. 富田修平

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results
3. 岡真優子

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Tanaka Masako 田中 昌子

橘昌子

橘 昌子 タチバナ マサコ

田中昌子

田中 昌子(橘昌子) タナカ マサコ

Research Projects

Research Products

Co-Researchers

Identification of multidrug resistance factors by analysis of Hsp70-interacting proteinsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

SDF-2 is involved in oxaliplatin resistance by maintaining ER homeostasisPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

HSP72 interactome identifies key molecules for intrinsic resitance to gemcitabine in pancreatic cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Generation of Rat Monoclonal Antibodies Specific for Human Stromal Cell-Derived Factor-22020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] A dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, attenuates cardiac dysfunction after myocardial infarction independently of DPP-42019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] HIF-1-dependent lipin1 induction prevents excessive lipid accumulation in choline-deficient diet-induced fatty liver2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Role of hypoxia-inducible factor-1 in the development of renal fibrosis in mouse obstructed kidney: Special references to HIF-1 dependent gene expression of profibrogenic molecules2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Heat shock protein 70 inhibitors suppress androgen receptor expression in LNCaP95 prostate cancer cells2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Gu&eacute;ren.2015

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Establishment of neutralizing rat monoclonal antibodies for fibroblast growth factor-22014

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Hsc70 contributes to cancer cell survival by preventing Rab1A degradation under stress conditions.2014

Author(s)

Journal Title

DOI

Data Source

[Presentation] Hsp72によるがん細胞遊走制御2019

Author(s)

Organizer

Data Source

[Presentation] Hsp72によるがん細胞遊走制御2019

Author(s)

Organizer

Data Source

[Presentation] アンドロゲン受容体の発現抑制を介したHsp70阻害剤の去勢抵抗性前立腺がんLNCaP95に対する抗がん作用2018

Author(s)

Organizer

Data Source

[Presentation] Stabilization of SDF-2 by Hsp72 contributes to oxaliplatin resistance in human gastric cancer cells2018

Author(s)

Tanaka Masako 田中昌子

橘昌子タチバナマサコ

田中昌子(橘昌子) タナカマサコ

[Journal Article] A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Guéren.2015